Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bruno

Showing results (341-350 of 355) with videos related to

Pageof 36
Sort By:
Neurology|March 21, 2009
Congenital muscular dystrophies with defective glycosylation of dystroglycan: a population studyE Mercuri, S Messina, C Bruno, et al.
Biorxiv : the Preprint Server for Biology|April 22, 2024
All-trans retinoic acid induces durable tumor immunity in IDH-mutant gliomas by rescuing transcriptional repression of the CRBP1-retinoic acid axisAparna Rao, Xiaoran Zhang, Anthony R Cillo, et al.
Cancer Cell|January 23, 2026
IFNγ-dependent metabolic reprogramming restrains an immature, pro-metastatic lymphatic state in melanomaTriantafyllia Karakousi, Vanessa Cristaldi, Maria Luiza Lopes de Oliveira, et al.
Science Translational Medicine|December 8, 2021
Prevalence of intratumoral regulatory T cells expressing neuropilin-1 is associated with poorer outcomes in patients with cancerChristopher A Chuckran, Anthony R Cillo, Jessica Moskovitz, et al.
Cell|April 7, 2023
Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatmentMackenzie J Bender, Alex C McPherson, Catherine M Phelps, et al.
Orphanet Journal of Rare Diseases|July 9, 2016
MYH7-related myopathies: clinical, histopathological and imaging findings in a cohort of Italian patientsC Fiorillo, G Astrea, M Savarese, et al.
Journal of Proteomics|January 15, 2018
MHC class I loaded ligands from breast cancer cell lines: A potential HLA-I-typed antigen collectionDmitri V Rozanov, Nikita D Rozanov, Kami E Chiotti, et al.
Neuromuscular Disorders : NMD|June 26, 2009
Reliability of the North Star Ambulatory Assessment in a multicentric settingE S Mazzone, S Messina, G Vasco, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 28, 2021
Intractable Coronavirus Disease 2019 (COVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication in a Chimeric Antigen Receptor-Modified T-Cell Therapy Recipient: A Case StudyMatthew K Hensley, William G Bain, Jana Jacobs, et al.
Nature Cancer|June 27, 2025
p95HER2, a truncated form of the HER2 oncoprotein, drives an immunosuppressive program in HER2<sup>+</sup> breast cancer that limits trastuzumab deruxtecan efficacyDong Hu, Xiaoshuang Lyu, Zheqi Li, et al.
Pageof 36

Showing results (341-350 of 355) with videos related to

Sort By:
Pageof 36
Neurology|March 21, 2009
Congenital muscular dystrophies with defective glycosylation of dystroglycan: a population studyE Mercuri, S Messina, C Bruno, et al.
Biorxiv : the Preprint Server for Biology|April 22, 2024
All-trans retinoic acid induces durable tumor immunity in IDH-mutant gliomas by rescuing transcriptional repression of the CRBP1-retinoic acid axisAparna Rao, Xiaoran Zhang, Anthony R Cillo, et al.
Cancer Cell|January 23, 2026
IFNγ-dependent metabolic reprogramming restrains an immature, pro-metastatic lymphatic state in melanomaTriantafyllia Karakousi, Vanessa Cristaldi, Maria Luiza Lopes de Oliveira, et al.
Science Translational Medicine|December 8, 2021
Prevalence of intratumoral regulatory T cells expressing neuropilin-1 is associated with poorer outcomes in patients with cancerChristopher A Chuckran, Anthony R Cillo, Jessica Moskovitz, et al.
Cell|April 7, 2023
Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatmentMackenzie J Bender, Alex C McPherson, Catherine M Phelps, et al.
Orphanet Journal of Rare Diseases|July 9, 2016
MYH7-related myopathies: clinical, histopathological and imaging findings in a cohort of Italian patientsC Fiorillo, G Astrea, M Savarese, et al.
Journal of Proteomics|January 15, 2018
MHC class I loaded ligands from breast cancer cell lines: A potential HLA-I-typed antigen collectionDmitri V Rozanov, Nikita D Rozanov, Kami E Chiotti, et al.
Neuromuscular Disorders : NMD|June 26, 2009
Reliability of the North Star Ambulatory Assessment in a multicentric settingE S Mazzone, S Messina, G Vasco, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 28, 2021
Intractable Coronavirus Disease 2019 (COVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication in a Chimeric Antigen Receptor-Modified T-Cell Therapy Recipient: A Case StudyMatthew K Hensley, William G Bain, Jana Jacobs, et al.
Nature Cancer|June 27, 2025
p95HER2, a truncated form of the HER2 oncoprotein, drives an immunosuppressive program in HER2<sup>+</sup> breast cancer that limits trastuzumab deruxtecan efficacyDong Hu, Xiaoshuang Lyu, Zheqi Li, et al.
Pageof 36